63177-41-3 Usage
Uses
Used in Organic Synthesis:
Azetidine, 1-(chloroacetyl)(9CI) is used as a reactive intermediate for the synthesis of various organic compounds. Its unique structure and functional group allow it to participate in a range of chemical reactions, facilitating the creation of diverse molecular architectures.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Azetidine, 1-(chloroacetyl)(9CI) is utilized as a building block for the development of pharmaceutical agents. Its structural features make it a promising candidate for the design of novel drugs with potential therapeutic applications.
Used in Research and Development:
Azetidine, 1-(chloroacetyl)(9CI) is also employed in research and development settings to explore its chemical properties and reactivity. This helps in understanding its potential applications and limitations, as well as in the discovery of new synthetic routes and methodologies.
Used in Pharmaceutical Industry:
Azetidine, 1-(chloroacetyl)(9CI) is used as a key component in the synthesis of pharmaceutical compounds. Its unique structure and reactivity contribute to the development of new drugs with improved efficacy and selectivity.
Used in Chemical Industry:
In the chemical industry, Azetidine, 1-(chloroacetyl)(9CI) is utilized in the production of specialty chemicals and intermediates. Its versatility in chemical reactions makes it a valuable asset for the synthesis of a wide range of chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 63177-41-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,1,7 and 7 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 63177-41:
(7*6)+(6*3)+(5*1)+(4*7)+(3*7)+(2*4)+(1*1)=123
123 % 10 = 3
So 63177-41-3 is a valid CAS Registry Number.
63177-41-3Relevant academic research and scientific papers
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
-
Paragraph 00441-00442; 00627, (2014/09/29)
The present invention discloses compounds according to Formula I: Wherein R1a, R1b, R2, R4, R5, R6a, R6b, R7, R8, W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseasesby administering the compound of the invention.
